Combined molecular biology test can identify patients with benign pancreatic abnormalities August 03, 2017Vol.40 No.07
Differences in subtypes may determine prognosis and response to treatment August 03, 2017Vol.40 No.07
UW study links insurance coverage to higher rates of colorectal cancer screenings August 03, 2017Vol.40 No.07
First-line immunotherapy treatment can improve survival for subset of lung cancer patients August 03, 2017Vol.40 No.07
Oral enasidenib demonstrates durable CRs in IDH2 mutant relapsed, refractory AML August 03, 2017Vol.40 No.07
Drugs & Targets FDA approves Vectibix for use in wild-type ras metastatic colorectal cancer July 06, 2017Vol.40 No.06
